NLRP3 and Hepatic fibrosis: Its strong anti-inflammatory effects and ability to modulate fibrotic progression suggest that NLRP3 inflammasome inhibition may be a promising therapeutic strategy not only for prevention but also for reversal of liver fibrosis.